Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Drug Formulation Market Growth Potential: How Will Market Size Change Through 2030?

The drug formulation market has experienced robust expansion in recent years. Valued at $2045.31 billion in 2025, it is projected to reach $2221.54 billion by 2026, reflecting a compound annual growth rate (CAGR) of 8.6%. Historical growth has been driven by factors such as the increasing demand for generic medications, a higher incidence of chronic conditions, progress in pharmaceutical research, the broadening of hospital and clinic infrastructure, and greater funding dedicated to research and development.

Over the coming years, the drug formulation market is anticipated to experience robust expansion, with projections indicating it will reach $3196.24 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.5%. This forecasted growth is primarily fueled by the rise of gene and cell therapies, the integration of artificial intelligence in drug design, the creation of innovative excipients, a growing focus on biologics and specialty medications, and the expansion of pharmaceutical markets in emerging regions. Key developments shaping this period include the advancement of personalized drug formulations, the evolution of sophisticated drug delivery systems, the progress in biologics and biosimilars, efforts to enhance formulation stability and extend shelf life, and a stronger emphasis on regulatory compliance and quality assurance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Drug Formulation Market Demand Drivers: What Is Fueling Industry Growth?

The growing embrace of personalized medicine is anticipated to accelerate the expansion of the drug formulation market in the foreseeable future. Personalized medicine represents a forward-thinking healthcare model that adapts medical treatments and interventions to the unique traits of each patient. It involves customizing therapies based on individual patient factors, including genetics and biomarkers. This method demands the creation of specialized drug formulations aimed at maximizing both effectiveness and safety for each person. Its consequences include the requirement for tailored treatment strategies, formulations that incorporate genomic information, improved drug responses, and customized therapies for uncommon diseases. For example, in 2023, the Personalized Medicine Coalition (PMC), a non-profit organization in the United States, reported that personalized medicines constituted approximately 38 percent of all newly approved therapeutic molecular entities, compared to 34 percent in 2022. Consequently, the rising adoption of personalized medicine is fueling the growth of the drug formulation market.

Drug Formulation Market Segment Analysis And Revenue Opportunities

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

Drug Formulation Market Innovation Trends: Which Developments Are Transforming The Industry?

Major players in the drug formulation industry are actively creating innovative fixed-dose combination therapies for type 2 diabetes in order to strengthen their market position. A fixed-dose combination (FDC) is defined as a pharmaceutical product that merges two or more active substances into a single delivery form, with doses present in a predetermined ratio. As an example, in October 2023, Glenmark Pharmaceuticals Limited, a company based in India, introduced its first triple-drug fixed-dose combination, marketed under the brand Zita DM. This formulation includes the DPP4 inhibitor Teneligliptin (20 mg), the SGLT2 inhibitor Dapagliflozin (10 mg), and Metformin SR (500 mg or 1000 mg), all combined in a fixed dose. Prescribed for once-daily use, it is intended to enhance glycemic control among individuals with Type 2 diabetes.

Drug Formulation Market Leading Players Shaping Industry Direction

Major companies operating in the drug formulation market are AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Access The Complete Drug Formulation Market Report:

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Drug Formulation Market Largest Region: Which Geography Holds The Highest Market Share?

North America was the largest region in the drug formulation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model